Planned Research



Assessment of ECMO in acute myocardial infarction with Non-reversible Cardiogenic shock to Halt Organ failure and Reduce mortality

ANCHOR is a multicenter, randomized, controlled trial. Its primary objective is to determine if early VA-ECMO in conjunction with optimal medical treatment would improve clinical outcomes 30 days following randomization as compared with optimal medical treatment alone in patients with acute myocardial infarction complicated by cardiogenic shock.


ECMO PT is a multicentre, randomised, trial of whether early individualised physical training (commenced within first 48 hours of ECMO) is feasible and improves functional recovery (the highest level of activity and duration) compared to standard care in ECMO patients.

Position Papers